167 related articles for article (PubMed ID: 33813137)
21. Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer.
Liu X; Liu X; Li J; Ren F
Med Sci Monit; 2019 Dec; 25():9280-9289. PubMed ID: 31805030
[TBL] [Abstract][Full Text] [Related]
22. MAP kinase-interacting serine/threonine kinase 2 promotes proliferation, metastasis, and predicts poor prognosis in non-small cell lung cancer.
Guo Z; Peng G; Li E; Xi S; Zhang Y; Li Y; Lin X; Li G; Wu Q; He J
Sci Rep; 2017 Sep; 7(1):10612. PubMed ID: 28878291
[TBL] [Abstract][Full Text] [Related]
23. Clinical significance of SOX9 in human non-small cell lung cancer progression and overall patient survival.
Zhou CH; Ye LP; Ye SX; Li Y; Zhang XY; Xu XY; Gong LY
J Exp Clin Cancer Res; 2012 Mar; 31(1):18. PubMed ID: 22385677
[TBL] [Abstract][Full Text] [Related]
24. Identification of key microRNAs and hub genes in non-small-cell lung cancer using integrative bioinformatics and functional analyses.
Song F; Xuan Z; Yang X; Ye X; Pan Z; Fang Q
J Cell Biochem; 2020 Mar; 121(3):2690-2703. PubMed ID: 31692035
[TBL] [Abstract][Full Text] [Related]
25. Hsa_circ_0001869 promotes NSCLC progression via sponging miR-638 and enhancing FOSL2 expression.
Xu P; Wang L; Xie X; Hu F; Yang Q; Hu R; Jiang L; Ding F; Mei J; Liu J; Xiao H
Aging (Albany NY); 2020 Nov; 12(23):23836-23848. PubMed ID: 33221767
[TBL] [Abstract][Full Text] [Related]
26. GSK3β overexpression indicates poor prognosis and its inhibition reduces cell proliferation and survival of non-small cell lung cancer cells.
Zeng J; Liu D; Qiu Z; Huang Y; Chen B; Wang L; Xu H; Huang N; Liu L; Li W
PLoS One; 2014; 9(3):e91231. PubMed ID: 24618715
[TBL] [Abstract][Full Text] [Related]
27. Bioinformatic analysis revealing mitotic spindle assembly regulated NDC80 and MAD2L1 as prognostic biomarkers in non-small cell lung cancer development.
Wei R; Wang Z; Zhang Y; Wang B; Shen N; E L; Li X; Shang L; Shang Y; Yan W; Zhang X; Ma W; Wang C
BMC Med Genomics; 2020 Aug; 13(1):112. PubMed ID: 32795325
[TBL] [Abstract][Full Text] [Related]
28. Dysregulation of ferroptosis may involve in the development of non-small-cell lung cancer in Xuanwei area.
Li G; Yang J; Zhao G; Shen Z; Yang K; Tian L; Zhou Q; Chen Y; Huang Y
J Cell Mol Med; 2021 Mar; 25(6):2872-2884. PubMed ID: 33528895
[TBL] [Abstract][Full Text] [Related]
29. Long non-coding RNA LUCAT1 is associated with poor prognosis in human non-small lung cancer and regulates cell proliferation via epigenetically repressing p21 and p57 expression.
Sun Y; Jin SD; Zhu Q; Han L; Feng J; Lu XY; Wang W; Wang F; Guo RH
Oncotarget; 2017 Apr; 8(17):28297-28311. PubMed ID: 28423699
[TBL] [Abstract][Full Text] [Related]
30. LncRNA EPIC1 promotes tumor angiogenesis via activating the Ang2/Tie2 axis in non-small cell lung cancer.
Hou Y; Jia H; Cao Y; Zhang S; Zhang X; Wei P; Xie J; Dong W; Wang B
Life Sci; 2021 Feb; 267():118933. PubMed ID: 33359744
[TBL] [Abstract][Full Text] [Related]
31. Decreased microRNA-132 and its function in human non-small cell lung cancer.
Liu X; Yan S; Pei C; Cui Y
Mol Med Rep; 2015 May; 11(5):3601-8. PubMed ID: 25607827
[TBL] [Abstract][Full Text] [Related]
32. High expression of miR-493-5p positively correlates with clinical prognosis of non small cell lung cancer by targeting oncogene ITGB1.
Liang Z; Kong R; He Z; Lin LY; Qin SS; Chen CY; Xie ZQ; Yu F; Sun GQ; Li CG; Fu D; Jiang GX; Chen J; Ma YS
Oncotarget; 2017 Jul; 8(29):47389-47399. PubMed ID: 28537888
[TBL] [Abstract][Full Text] [Related]
33. Targeting histone methyltransferase G9a inhibits growth and Wnt signaling pathway by epigenetically regulating HP1α and APC2 gene expression in non-small cell lung cancer.
Zhang K; Wang J; Yang L; Yuan YC; Tong TR; Wu J; Yun X; Bonner M; Pangeni R; Liu Z; Yuchi T; Kim JY; Raz DJ
Mol Cancer; 2018 Oct; 17(1):153. PubMed ID: 30348169
[TBL] [Abstract][Full Text] [Related]
34. Suppression of Ubiquitin-Specific Peptidase 17 (USP17) Inhibits Tumorigenesis and Invasion in Non-Small Cell Lung Cancer Cells.
Zhang S; Yuan J; Zheng R
Oncol Res; 2016; 24(4):263-9. PubMed ID: 27656837
[TBL] [Abstract][Full Text] [Related]
35. Identification and validation of key genes associated with non-small-cell lung cancer.
Ma Q; Xu Y; Liao H; Cai Y; Xu L; Xiao D; Liu C; Pu W; Zhong X; Guo X
J Cell Physiol; 2019 Dec; 234(12):22742-22752. PubMed ID: 31127628
[TBL] [Abstract][Full Text] [Related]
36. Decreased microRNA-224 and its clinical significance in non-small cell lung cancer patients.
Zhu D; Chen H; Yang X; Chen W; Wang L; Xu J; Yu L
Diagn Pathol; 2014 Nov; 9():198. PubMed ID: 25410592
[TBL] [Abstract][Full Text] [Related]
37. Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis.
Wang L; Qu J; Liang Y; Zhao D; Rehman FU; Qin K; Zhang X
Thorac Cancer; 2020 Apr; 11(4):851-866. PubMed ID: 32059076
[TBL] [Abstract][Full Text] [Related]
38. Knockdown of HJURP inhibits non-small cell lung cancer cell proliferation, migration, and invasion by repressing Wnt/β-catenin signaling.
Wei Y; Ouyang GL; Yao WX; Zhu YJ; Li X; Huang LX; Yang XW; Jiang WJ
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3847-3856. PubMed ID: 31115012
[TBL] [Abstract][Full Text] [Related]
39. Upregulation of phosphoserine phosphatase contributes to tumor progression and predicts poor prognosis in non-small cell lung cancer patients.
Liao L; Yu H; Ge M; Zhan Q; Huang R; Ji X; Liang X; Zhou X
Thorac Cancer; 2019 May; 10(5):1203-1212. PubMed ID: 30977310
[TBL] [Abstract][Full Text] [Related]
40. Contributions of KRAS and RAL in non-small-cell lung cancer growth and progression.
Guin S; Ru Y; Wynes MW; Mishra R; Lu X; Owens C; Barn AE; Vasu VT; Hirsch FR; Kern JA; Theodorescu D
J Thorac Oncol; 2013 Dec; 8(12):1492-501. PubMed ID: 24389431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]